Moneycontrol PRO
Loans

business

Claris at new high, up 20% on sale of injectable biz to Baxter

Claris Lifesciences shares hit a record high of Rs 430.10, up 20 percent intraday Friday after the company sold its injectable business to US healthcare company.

first published: Dec 16, 2016 10:59 am

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347